Dublin, Nov. 14, 2017 -- The "Clinical Chemistry Markets (by Type [Instrument, Reagent], by Analyte [Glucose, Electrolytes, Cardiac Biomarkers, Enzymes, Proteins, Drugs of Abuse, Therapeutic Drugs, HbA1c, Others], by Region)" report has been added to Research and Markets' offering.
Global demand for clinical chemistry products is projected to increase 2.8 percent annually to $19.7 billion in 2021
At nearly one-sixth of the overall IVD market, clinical chemistry procedures are a large part of clinical testing. These procedures measure levels of naturally produced and externally consumed compounds (i.e., therapeutic and illicit drugs and toxicants) in the body to detect potential diseases and other medical conditions, assess general health status, and monitor therapies.
Clinical Chemistry Markets report, examines the global market for clinical chemistry products and procedures. Among the products covered are instruments, reagents, and supporting consumables used worldwide in core laboratory and point-of-care (POC) medical testing. Clinical chemistry instruments consist of large multifunctional workstations capable of conducting multiple procedures simultaneously as well as smaller analyzers dedicated to narrower, more specific applications.
Workstations detailed in this report include systems used exclusively for clinical chemistry testing and combination systems with both clinical chemistry and immunoassay testing capabilities. POC systems analyzed consist of dedicated clinical chemistry instruments sold to professional healthcare markets only. Equipment used directly by patients is excluded from the content.
Advances in technology have led to the incorporation of various immunoassay procedures on clinical chemistry workstations. Immunoassay tests detect and measure analytes in the body by assessing antigen and antibody reactions in patient specimens.
Reliable Clinical Chemistry Business Data:
- Core Laboratory Chemistry Product Demand by Type
- Global Core Laboratory Chemistry Reagent Demand by Type
- Commonly Measured Core Laboratory Chemical Analytes
- Global Core Laboratory Chemistry Standards & Controls Market
- Global Core Laboratory Chemistry Instruments Market
- Global Core Laboratory Immunochemistry Instrument Markets
- Global Core Laboratory Immunochemistry Reagent Market
- Common Analytes on Workstations (Glucose Market, Electrolytes Market, Cardiac Biomarkers Market, Enzymes Market, Proteins Market, Drugs of Abuse Market, Therapeutic Drugs Market, HbA1c Market, Other Commonly Tested Analytes)
- Global Core Laboratory Chemistry/Immunoassay Combination Workstation Demand
- Selected Chemistry/Immunoassay Workstations on the Market
- Professional POC Clinical Chemistry Testing Products by Type (million US dollars)
- Reagents for Clinical Chemistry
- Instruments for Clinical Chemistry
Key Topics Covered:
1: Executive Summary
- Scope And Methodology
- Size And Growth Of The Global Market
- Summary Table - Clinical Chemistry Products Demand by Type (million dollars)
2: Global Market Environment
- Demographic Trends
- Total Population
- Age Distribution
- Global Healthcare Trends
- Chronic Conditions
- Health Expenditures
- Hospitals
- Physicians
- Clinical Laboratories
- Patient Activity
- IVD Tests
3. Clinical Chemistry Procedures
- Lab-Based Chemistry Tests
- General Chemistry
- Blood Gases & Electrolytes
- Urinanalysis
- Workstation Immunoassay Tests
- Cardiac Markers
- Tumor Markers
- Infectious Disease Markers
- Vitamin D
- Thyroid Markers
- Hormones
- Other Analytes
- Professional Poc Tests
- Glucose Testing
- Cardiac Markers
- Drugs of Abuse
- HbA1c
- Other Analytes
4. Clinical Chemistry Products
- Core Laboratory Chemistry Products
- Technologies
- Reagents
- Standards & Controls
- Lab-Based Chemistry Instruments
- Immunoassays On Core Laboratory Workstations
- Technology
- Reagents
- Instruments
- Poc Clinical Chemistry Products
- Reagents
- Instruments
5. Regional Market Characteristics
6. Profiles Of Key Players
- Abbott Laboratories
- Beckman Coulter
- A. Menarini Diagnostics
- Abbott Laboratories
- Acon Laboratories, Inc.
- Alere Inc.
- Arkray, Inc.
- Beckman Coulter
- Bio-Rad Laboratories
- Carolina Liquid Chemistries Corp.
- Diatron MI ZRT
- EKF Diagnostics Holdings Plc
- Elitechgroup
- Erba Diagnostics
- Horibalimited
- Nova Biomedical
- Ortho Clinical Diagnostics
- Radiometer Medical Aps
- Randox Laboratories Ltd.
- Roche Holding Limited
- Sekisui Diagnostics
- Siemens
- Sysmex
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/research/sv2n33/clinical
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Enzymes , Biopharmaceuticals , Biomarkers , Addiction Disorders Drugs


Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
Samsung Electronics Shares Jump on HBM4 Mass Production Report
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push 



